6.180USD-0.16%Mkt Cap: 1.08B USDP/E: 89.50Last update: 2026-05-26
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-u…
Industry Peers
Drug Manufacturers - Specialty & Generic155.29BSEKP/E 172.0
58.11BTRYP/E 27.8
56.52BEURP/E 22.3
33.63BPLNP/E 21.9
24.50BUSDP/E 21.3
18.90BUSD—
15.76BUSDP/E 24.1
13.30BSEKP/E 40.0
Indicators:|
Key Statistics
Company
Market Cap1.08B USD
Enterprise Value1.25B USD
Revenue (TTM)314.85M USD
Gross Profit249.28M USD
Net Income (TTM)554.00K USD
Revenue/Share1.909 USD
Last Price6.180 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees435
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS98422E1038
Valuation
P/E (Trailing)89.50
P/E (Forward)16.15
PEG—
EV/EBITDA25.96
EV/Revenue3.96
P/S3.50
P/B77.80
EPS (TTM)0.07
EPS (Forward)0.40
52W Range
4.30033% of range10.08
52W High10.08 USD
52W Low4.300 USD
Profitability
Gross Margin85.41%
Oper. Margin9.52%
EBITDA Margin15.27%
Profit Margin0.19%
ROE4.05%
ROA0.14%
Growth
Revenue Growth38.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF28.63M USD
CapEx (TTM)696.00K USD
FCF Margin13.40%
FCF Yield3.90%
Net Debt146.80M USD
Net Debt/EBITDA3.05
Balance Sheet
Debt/Equity18.85
Current Ratio2.12
Quick Ratio1.42
Book Value/Sh0.0820 USD
Cash/Share0.6470 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)11.29 USD
Target Range8.000 USD – 18.00 USD
# Analysts7
Ownership
Shares Out.172.64M
Float163.84M
Insiders3.35%
Institutions62.35%
Short Interest
Short Ratio11.1d
Short % Float9.53%
Short % Out.9.21%
Shares Short15.89M
Short (prev mo.)16.41M
Technical
SMA 505.970 (+3.5%)
SMA 2007.134 (-13.4%)
Beta0.92
S&P 52W Chg28.31%
Avg Vol (30d)1.56M
Avg Vol (10d)1.71M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—